Obesity due to disruption of MC4R pathway
Billable / specific
E88.82 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Includes (from E88)
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
- transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E88)
- androgen insensitivity syndrome (E34.5-) (from E88)
- congenital adrenal hyperplasia (E25.0) (from E88)
- hemolytic anemias attributable to enzyme disorders (D55.-) (from E88)
- Marfan syndrome (Q87.4-) (from E88)
- 5-alpha-reductase deficiency (E29.1) (from E88)
- histiocytosis X (chronic) (C96.6) (from E88)
Excludes2
Not included here — may be reported together when both conditions exist.
Use additional code
Add a code to identify the following, if applicable.
Also known as
- Obesity, due to disruption of MC4R pathway
- Obesity, due to gene mutation, leptin
- Obesity, due to gene mutation, leptin receptor
- Obesity, due to gene mutation, melanocortin 4 Receptor
- Obesity, due to gene mutation, nuclear receptor coactivator 1
- Obesity, due to gene mutation, proopiomelanocortin
- Obesity, due to gene mutation, proprotein convertase subtilisin/kexin type 1
- Obesity, due to gene mutation, src homology 2B adaptor signaling protein
Parent code
- E88.8Other specified metabolic disordersHeader